Abstract
The Emergency Ventricular Support (EVS) is an innovative cardiological device, belonging to the Ventricular Assist Device (VAD) category. Is is a contrivance that, due to its unique capability to be installed in a very short time and to assist or replace completely the heart functionality of pumping the blood for a period of time long enough to put in place the necessary medical measures, it can be reversibly applied to the following major purposes:
Prevention
EVS will represent a significant evolutive change of the current therapeutic approach to the heart attack, as it will allow for the adoption of medical protocols more prevention oriented than they are today. For instance, targeting sets of population of individuals ranked as at high risk of heart attack, campaigns of invasive preventive exams could be launched thanks to the use of EVS that will minimize the risks so achieving the double result of:
Carrying out an healing intervention, if deemed as necessary, meanwhile performing the blood vessel examination;
Achieving a deep (EVS enables a time independent investigation) awareness of the status of the patient so to prescribe the best cure to prolong his life with the highest level of quality attainable.
Treatment of Heart Attack or other Heart Pathologies
The high reliability of the double pulsatile blood pump and the associated control & management unit, compliant with the applicable quality and safety critical standard, completes the disruptive innovation brought by EVS in the current best practices of heart diseases’ prevention, surgery and treatments.
IP Status
Italian patent no. 102018000006538
granted on 08 July 2020
US patent 11,951,296 B2
granted on 09 April 2024
Media
MLB PoC
Giuseppe Mele
- CEO and Legal Representative
- (+39) 392 945 5665
- info@mlb-innovation.com
